Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Submitted by
admin
on March 21, 2018 - 9:20am
Source:
Fierce Biotech
News Tags:
Prothena
Celgene
R&D
TDP-43
anti-tau antibodies
Alzheimer's disease
Headline:
Prothena, Celgene ink neuro R&D pact potentially worth $2B+
Do Not Allow Advertisers to Use My Personal information
